A two-part grant is designed to provide guidance on gaps in existing guidelines on the management of advanced prostate cancer, Neal D. Shore, MD, reported at the LUGPA annual meeting in Chicago.
Richard R. Kerr
Jeb Bush touched on a range of issues in health care and politics and shared a few personal anecdotes about his famous family with LUGPA members at the association’s annual meeting in Chicago.
Urologists face a significant risk of on-the-job pain and injury, an exclusive Urology Times survey has found.
"Based on their lines of questioning, it was apparent the defendant’s attorney wanted me to sit on the jury and the plaintiff’s attorney did not," writes Urology Times Content Channel Director Richard R. Kerr.
A pivotal phase II trial of a novel MRI-guided ultrasound ablation treatment exceeded its primary efficacy endpoint of PSA decline in men with organ-confined prostate cancer.
In advance of this year’s AUA annual meeting, Urology Times asked members of our editorial board to choose the top presentations in their subspecialty.
More than one-fourth of urologists say they have specific plans to retire within the next 2 years. An ongoing drop in reimbursement, feeling burned out, and government mandates are the primary factors affecting when they will retire, according to the 13th annual Urology Times State of the Specialty survey.
Changes in the Medicare fee schedule, including plans to pay essentially the same amount for services whether performed in a hospital provider-based department (PBD) or in individual physician offices, were hailed as “significant wins” in a Health Policy Forum at the 2018 LUGPA annual meeting in Chicago.
At 10th anniversary meeting, Neal D. Shore, MD, discusses what has made LUGPA “decidedly unique” from other urologic associations.
Even though patients with muscle-invasive bladder cancer and significant comorbidity are likely to benefit from bladder-sparing treatment approaches, increasing comorbidity burden appears to have no correlation with receiving such treatments.